M
Maverick BioMetals
Bioextraction is at the frontier of biomining technology built for the clean energy powering the green future
About Maverick BioMetals
Maverick BioMetals is a biotechnology firm focused on advancing mineral processing and metal extraction to address the inefficiencies and environmental impact of conventional mining. Founded in 2022 by Eric Herrera and Jesse Evans, the San Antonio-based company is developing biological methods for producing critical materials like lithium and silicon. The founders, who met during their first year at Washington and Lee University, bring complementary skills to the venture; Herrera, with a scientific background from the Department of Defense and a childhood in a small Mexican mining town, serves as CEO, while Evans contributes his experience as a startup operations manager. The partnership was born from a shared vision to apply biology to industrial challenges, leading Herrera to decline a medical school scholarship and Evans to leave a tech job to pursue their startup in Silicon Valley.
The company's core technology is a proprietary synthetic enzyme called "LithX," which chemically breaks down the crystal structure of hard rock ores to extract metals. This bio-extraction process operates at near-ambient temperatures and neutral pH levels, offering a lower-energy and safer alternative to traditional methods like acid roasting, which are energy-intensive and produce hazardous byproducts. Maverick's process is designed to completely solubilize ores, enabling the recovery of a wide range of metals including lithium, copper, nickel, cobalt, and rare earth elements, while also mitigating the risk of acid contamination. The technology is not limited to primary extraction; it can be adapted for challenging ore bodies, mining wastes, and even shale, allowing the company to design tailored solutions for its clients.
Maverick BioMetals' business model centers on forming partnerships with mining companies to commercialize and deploy its technology. The firm works directly with these clients to test its process on their specific materials and develop site-specific flowsheets to unlock value from unconventional or previously uneconomical resources. The company was part of the Y Combinator S22 cohort and has secured significant funding to scale its operations. After starting with just $214 on a single bench in a Baltimore basement, the company has grown into a 10,000 sq. ft. laboratory. Maverick has raised a total of $9.64M over three funding rounds, including a Series A and a grant from the Office of Scientific and Technical Information (OSTI). This capital is being used to expand pilot deployments with major mining partners and accelerate commercialization efforts.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 27
- Open positions
- None listed
- Dealroom signal
- 91.0/100
- Industry
- Energy, Chemicals
- Sector
- Mining Technologies, Biotechnology, Copper, YC S22, NIF defense security and resilience, NIF Supply Chain Resilience, DT and LS, science-based
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Apr 2025 | $19M | $76M | Liquid 2 Ventures · Soma Capital · Hanwha · Nomadic Venture Partners | ↗ |
| GRANT✓Other financing | Mar 2024 | $2K | — | City Of San Antonio | ↗ |
Growth signals
Latest recorded traffic for Maverick BioMetals is 390 monthly website visits, up 11.4% over the last three months. Maverick BioMetals's team grew 12.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Maverick BioMetals in the San Francisco ecosystem
The Maverick BioMetals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Y Combinator
City Of San Antonio
Series A6 investors entered at this stage
Olive Tree Capital
Liquid 2 Ventures
Soma Capital
Hanwha
Nomadic Venture Partners
TechNexus
Other known investors4 additional known investors
Juniper
MetaPlanet
Neer Venture Partners
Prospect Innovation
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Maverick BioMetals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Maverick BioMetals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










